Home / Entreprenuers / GW Pharma CEO talks Epidiolex sales, potential CBD treatment for PTSD

GW Pharma CEO talks Epidiolex sales, potential CBD treatment for PTSD


GW Pharmaceutical CEO Justin Gover tells “Mad Money” host Jim Cramer the corporate offered $300 million price of its CBD-based epilepsy drug in 2019 and different therapies within the pipeline.

Source link

About Beverly Hall

Beverly D. Hall writes for Entreprenuers and Leadership sections in AmericaRichest.

Check Also

Watch CNBC's full interview with Berkshire Hathaway CEO Warren Buffett

Berkshire Hathaway’s chairman and CEO Warren Buffett sat down with CNBC’s Becky Quick on Monday …

Leave a Reply

Your email address will not be published. Required fields are marked *